ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s other income expense for the three months ended in Jun. 2013 was $0.1 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2013 was $-0.7 Mil.
Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.
Onyx Pharmaceuticals, Inc. Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2013 was -0.569 (Sep. 2012 ) + -0.051 (Dec. 2012 ) + -0.156 (Mar. 2013 ) + 0.094 (Jun. 2013 ) = $-0.7 Mil.
Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data